Causes of poor adherence to disease-modifying antirheumatic drugs in Mexican patients with rheumatoid arthritis

被引：0
|
作者：
Morales-Romero, J [1 ]
González-López, L [1 ]
Rodríguez-Arreola, BE [1 ]
Celis, A [1 ]
Gémez-Nava, JI [1 ]
机构：
[1] Univ Guadalajara, CUCS, Guadalajara 44430, Jalisco, Mexico
来源：
JOURNAL OF RHEUMATOLOGY | 2006年 / 33卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：406 / 406
页数：1
相关论文
共 50 条
  • [41] Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis
    Lacaille, Diane
    Guh, Daphne P.
    Abrahamowicz, Michal
    Anis, Aslam H.
    Esdaile, John M.
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (08): : 1074 - 1081
  • [42] FACTORS ASSOCIATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS UTILIZATION IN RHEUMATOID ARTHRITIS PATIENTS
    Hosseini, R.
    Brown, L.
    Rodriguez-Monguio, R.
    Seoane-Vazquez, E.
    VALUE IN HEALTH, 2022, 25 (07) : S453 - S453
  • [43] Influence of disease-modifying antirheumatic drugs on oxidative and nitrosative stress in patients with rheumatoid arthritis
    Neide Tomimura Costa
    Tatiana Mayumi Veiga Iriyoda
    Daniela Frizon Alfieri
    Andréa Name Colado Simão
    Isaias Dichi
    Inflammopharmacology, 2018, 26 : 1151 - 1164
  • [44] TREATMENT ADHERENCE TO CONVENTIONAL AND BIOLOGIC DISEASE MODIFYING ANTIRHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Feldman, C. H.
    Lii, J.
    Gopalakrishnan, C.
    Franklin, J. M.
    Kim, S. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 526 - 526
  • [45] Use of disease-modifying antirheumatic drugs in patients with psoriatic arthritis
    Marguerie, L
    Flipo, RM
    Grardel, B
    Beaurain, D
    Duquesnoy, B
    Delcambre, B
    JOINT BONE SPINE, 2002, 69 (03) : 275 - 281
  • [46] Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis
    Nandi, Pradip
    Kingsley, Gabrielle H.
    Scott, David L.
    CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (03) : 251 - 256
  • [47] Treatment Satisfaction With and Adherence to Disease-Modifying Antirheumatic Drugs in Adult Patients With Juvenile Idiopathic Arthritis
    Tollisen, Anita
    Flato, Berit
    Selvaag, Anne M.
    Aasland, Astrid
    Ingebrigtsen, Trude
    Sagen, Joachim
    Lerdal, Anners
    ARTHRITIS CARE & RESEARCH, 2021, 73 (02) : 221 - 231
  • [48] The Risk of Cardiovascular Events Associated With Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis
    Ozen, Gulsen
    Pedro, Sofia
    Michaud, Kaleb
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (05) : 648 - 655
  • [49] Pharmacotherapeutic combination strategies with disease-modifying antirheumatic drugs in established rheumatoid arthritis
    van Riel, PLCM
    Haagsma, CJ
    Furst, DE
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 1999, 13 (04): : 689 - 700
  • [50] SAFETY OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN JUVENILE RHEUMATOID-ARTHRITIS (JRA)
    KVIEN, TK
    HOYERAAL, HM
    SANDSTAD, B
    KASS, E
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1984, : 112 - 112
12345